73 related articles for article (PubMed ID: 6810520)
1. The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria.
Mohammed I; Damisah MM
Trans R Soc Trop Med Hyg; 1982; 76(3):351-3. PubMed ID: 6810520
[TBL] [Abstract][Full Text] [Related]
2. Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.
Mohammed I; Onyemelukwe GC; Obineche EN; Gupta N; Oyeyinka GO
J Infect; 1984 Sep; 9(2):197-202. PubMed ID: 6438245
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen.
Ruben FL; Hankins WA; Zeigler Z; Norden CW; Harrison A; Winkelstein A; Herrmann DJ
Am J Med; 1984 Jan; 76(1):115-21. PubMed ID: 6419602
[TBL] [Abstract][Full Text] [Related]
4. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
[TBL] [Abstract][Full Text] [Related]
5. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine.
Rosenqvist E; Tjade T; Frøholm LO; Frasch CE
NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704
[TBL] [Abstract][Full Text] [Related]
6. The duration of the antibody response to meningococcal vaccination in an African village.
Greenwood BM; Whittle HC; Bradley AK; Fayet MT; Gilles HM
Trans R Soc Trop Med Hyg; 1980; 74(6):756-60. PubMed ID: 6782720
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell trait and the immune response to meningococcal vaccines.
Blakebrough IS; Greenwood BM; Whittle HC; Bradley AK; Akintunde A
Trans R Soc Trop Med Hyg; 1981; 75(6):905-6. PubMed ID: 6800076
[No Abstract] [Full Text] [Related]
8. The antimeningococcal vaccine VAMENGOC B-C induced poor serum and salivary antibody response in young Brazilian children.
Carbonare SB; Arslanian C; Silva ML; Farhat CK; Carneiro-Sampaio MM
Pediatr Infect Dis J; 1995 Sep; 14(9):797-803. PubMed ID: 8559631
[TBL] [Abstract][Full Text] [Related]
9. [The effect of vaccination on local immunity indices; the determination of antimeningococcal antibodies in saliva].
Martynov IuV; Marinin IIu; Deviatkina NN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):55-8. PubMed ID: 1801492
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
[TBL] [Abstract][Full Text] [Related]
11. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of children during treatment for leukemia.
Rautonen J; Siimes MA; Lundström U; Pettay O; Lanning M; Salmi TT; Penttinen K; Käyhty H; Leinonen M; Mäkelä PH
Acta Paediatr Scand; 1986 Jul; 75(4):579-85. PubMed ID: 3092561
[TBL] [Abstract][Full Text] [Related]
15. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
[TBL] [Abstract][Full Text] [Related]
16. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
García Moreno J; Prat Miranda MS; Vicent P; Calderón B
Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
[No Abstract] [Full Text] [Related]
17. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
[No Abstract] [Full Text] [Related]
18. Impairment of the immune response to vaccination after acute malaria.
Williamson WA; Greenwood BM
Lancet; 1978 Jun; 1(8078):1328-9. PubMed ID: 78096
[TBL] [Abstract][Full Text] [Related]
19. [Humoral immune response to the proteins of an antimeningococcal BC vaccine in a trial carried out in Antioquia, Colombia].
Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Blanco González R; Martínez Ruiz O; Martínez Fernández OM; Aguirre Muñoz CA
Bol Oficina Sanit Panam; 1995 Apr; 118(4):285-94. PubMed ID: 7779283
[TBL] [Abstract][Full Text] [Related]
20. [Humoral immune response to the capsular polysaccharide of Neisseria meningitidis serogroup C in an antimeningococcal BC vaccination trial in Antioquia, Colombia].
Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Martínez Ruiz O; Nerey MC; Camarasa MA; Bacallao Gallestey J
Bol Oficina Sanit Panam; 1995 Apr; 118(4):295-301. PubMed ID: 7779284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
